HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tc-99m sestamibi before and during treatment in a patient with sarcoidosis and persistent hyperparathyroidism.

AbstractPURPOSE:
Tc-99m sestamibi (MIBI) uptake in pulmonary sarcoidosis has been reported, but it has never been studied before and during treatment with glucocorticoids.
METHODS:
The authors performed MIBI scintigraphy and somatostatin receptor scintigraphy in a patient with sarcoidosis of the mediastinum, lungs, and liver and who had persistent hyperparathyroidism after unsuccessful neck exploration.
RESULTS:
Somatostatin receptor scintigraphy showed high mediastinal and pulmonary uptake in a pattern characteristic of sarcoidosis. Sustained MIBI uptake occurred in the same, although smaller, region. After the diagnosis was confirmed by liver biopsy, the patient was treated with glucocorticoids. Repeated MIBI scintigraphy showed that the uptake in the mediastinum had clearly decreased.
CONCLUSIONS:
This decrease of MIBI uptake in the mediastinal lymph nodes with therapy may imply that MIBI can be used to assess the response to treatment in sarcoidosis. Perhaps a relation exists between MIBI uptake at the moment of diagnosis and prognosis. Further studies in more patients are needed to evaluate the role of MIBI in the management of sarcoidosis.
AuthorsA C Fröberg, W W De Herder, H Jaap Bonjer, E P Krenning, H Yoe Oei, D J Kwekkeboom
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 25 Issue 5 Pg. 351-3 (May 2000) ISSN: 0363-9762 [Print] United States
PMID10795693 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
  • Receptors, Somatostatin
Topics
  • Diagnosis, Differential
  • Glucocorticoids (therapeutic use)
  • Humans
  • Hypercalcemia (diagnostic imaging, drug therapy)
  • Hyperparathyroidism (diagnostic imaging, drug therapy)
  • Liver (diagnostic imaging)
  • Lung (diagnostic imaging)
  • Lymph Nodes (diagnostic imaging)
  • Mediastinum (diagnostic imaging)
  • Receptors, Somatostatin (analysis)
  • Sarcoidosis (diagnostic imaging, drug therapy)
  • Sarcoidosis, Pulmonary (diagnostic imaging, drug therapy)
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: